Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite‐based chemotherapy
- 2 March 2007
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 48 (5) , 582-585
- https://doi.org/10.1002/pbc.20592
Abstract
While the disease‐free survival of acute promyelocytic leukemia (APML) now approaches 75%, some children continue to experience relapses, and questions remain as to the optimal management of these patients. We describe two young children who experienced combined relapses in the bone marrow and extramedullary locations following hematopoietic stem cell transplantation (HSCT). An induction regimen, consisting of all‐trans retinoic acid (ATRA), methotrexate, and 6‐mercaptopurine (6MP), successfully and safely achieved hematologic remission in one patient and molecular remission in the other. These cases demonstrate that there is a role for ATRA plus differentiating chemotherapy other than arsenic trioxide in the treatment of relapsed APML. Pediatr Blood Cancer 2007;48:582–585.Keywords
This publication has 18 references indexed in Scilit:
- Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two casesAnnals of Hematology, 2004
- Outcome of Childhood Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid and ChemotherapyJournal of Clinical Oncology, 2004
- Sweet Syndrome Developing During Treatment With All-Trans Retinoic Acid in a Child With Acute Myelogenous LeukemiaJournal of Pediatric Hematology/Oncology, 2004
- Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantationBlood, 2003
- Retinoic acid syndrome: manifestations, pathogenesis, and treatmentBest Practice & Research Clinical Haematology, 2003
- Treatment options for relapsed acute promyelocytic leukaemiaBest Practice & Research Clinical Haematology, 2003
- Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rateLeukemia, 2003
- Pulsed ATRA as single therapy restores long-term remission in PML-RARα-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot studyLeukemia, 2001
- The role of bone marrow transplantation in acute promyelocytic leukemiaBone Marrow Transplantation, 2001
- Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in childrenAnnals of Hematology, 2001